chr7-105481072-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 2P and 14B. PM2BP4_ModerateBP6_Very_StrongBS1
The NM_019042.5(PUS7):c.1155C>A(p.Val385=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,611,458 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000056 ( 1 hom. )
Consequence
PUS7
NM_019042.5 synonymous
NM_019042.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.241
Genes affected
PUS7 (HGNC:26033): (pseudouridine synthase 7) Enables enzyme binding activity and pseudouridine synthase activity. Involved in several processes, including pseudouridine synthesis; regulation of hematopoietic stem cell differentiation; and regulation of mesoderm development. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 7-105481072-G-T is Benign according to our data. Variant chr7-105481072-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 715610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000742 (113/152284) while in subpopulation AFR AF= 0.00257 (107/41564). AF 95% confidence interval is 0.00218. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PUS7 | NM_019042.5 | c.1155C>A | p.Val385= | synonymous_variant | 9/16 | ENST00000469408.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PUS7 | ENST00000469408.6 | c.1155C>A | p.Val385= | synonymous_variant | 9/16 | 1 | NM_019042.5 | P1 | |
PUS7 | ENST00000356362.6 | c.1155C>A | p.Val385= | synonymous_variant | 9/16 | 2 | P1 | ||
PUS7 | ENST00000481939.5 | c.1155C>A | p.Val385= | synonymous_variant, NMD_transcript_variant | 9/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000716 AC: 109AN: 152166Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
109
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000177 AC: 44AN: 249198Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134722
GnomAD3 exomes
AF:
AC:
44
AN:
249198
Hom.:
AF XY:
AC XY:
17
AN XY:
134722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000555 AC: 81AN: 1459174Hom.: 1 Cov.: 30 AF XY: 0.0000482 AC XY: 35AN XY: 725850
GnomAD4 exome
AF:
AC:
81
AN:
1459174
Hom.:
Cov.:
30
AF XY:
AC XY:
35
AN XY:
725850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000742 AC: 113AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000698 AC XY: 52AN XY: 74448
GnomAD4 genome
AF:
AC:
113
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
52
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | PUS7: BP4, BP7 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2018 | - - |
PUS7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 19, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at